University Hospital Bonn
Bonn, North Rhine-Westphalia, 53113, Germany
Location status: Recruiting
Location contact
Andreas C. Strauss, PD Dr. med.
CONTACT
Andreas C. Strauss, PD Dr. med.
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06352216
The aim of this study is to evaluate the prevalence of synovitis in adult patients with haemophilia A.
Interested in participating?
Request Info18 year and older
Male
Observational
Bonn, North Rhine-Westphalia, 53113, Germany
Location status: Recruiting
Andreas C. Strauss, PD Dr. med.
CONTACT
Andreas C. Strauss, PD Dr. med.
PRINCIPAL_INVESTIGATOR
The bleeding disorder haemophilia causes recurrent spontaneous bleedings primarily into the joints and soft tissues. The reason is a congenital lack of factor VIII (haemophilia A) or factor IX (haemophilia B). In Germany, the most affected joints are the ankle, knee, and elbow. The joint bleedings are accompanied by pain and an inflammatory process that leads to synovitis and ultimately to degenerative joint changes resulting in haemophilic arthropathy: The synovial tissue is responsible for removing blood residuals from the joint cavity. However, blood components, especially iron, induce several changes in the synovial tissue. The resulting synovitis leads to damage of cartilage, bone cysts, osteophytes, and joint effusions. Synovitis can even become a bleeding-independent process, especially after repeated bleeding. According to current knowledge, there is no option to prevent synovitis except for preventing bleedings.
In the aftermath of recurrent joint bleedings, various changes in the synovial tissue, the articular cartilage, and the subchondral bone and blood vessels are observed. These changes are accompanied by restricted joint mobility and musculoskeletal dysfunction. In addition to these peripheral structural changes, various studies show that the entire musculoskeletal system is also affected by recurrent joint bleedings, as it adapts to pain.
Improved therapy over the past decades has led to a reduction in major joint bleeding rates. For this reason, it is important to examine whether this has improved the average joint status and how often patients with haemophilia (PwH) are affected by synovitis at all. Sonography is the radiation-free method of choice for the initial determination of synovitis.
In addition to the structural consequences, joint bleedings also lead to pain and reduction in physical performance. When considering the overall process of degenerative joint changes of PwH, it becomes apparent that this also reduces daily mobility and muscle strength. To the best of our knowledge, the effects of the degree of synovitis on pain perception and physical performance have not been evaluated in previous studies.
For this reason, the prevalence of synovitis in PwH and the consequences in relation to the pain situation and physical performance will be investigated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each subject is examined for the presence of synovitis using the aforementioned diagnostics.
Time frame: 20 minutes
HEAD-US protocol examines both elbow, knee and ankle joints sonographically and assesses the presence of synovitis or joint damage from 0-8 points per joint according to Martinoli et al. 2013. A "total score" of 0 to 48 points is achievable. A higher score means a worse joint status.
Time frame: 45 minutes
Clinical joint examination according to De la Corte-Rodriguez et al. 2020. HJHS protocol examines both elbow, knee and ankle joints using a goniometer for range of motion and axial alignment (0-3 points), pain numerical rating scale (0-10 points), swelling (0-3 points), crepitation (0-2 points) and gait abnormalities (0-4 points). A "total score" of 0 to 124 points is achievable. A higher score means a worse joint status.
Time frame: 10 minutes
Patient-reported outcomes are surveyed using short questionnaires with a stable number of items from seven PROMIS sub scales ("depression", "anxiety", "physical functioning", "impairment due to pain", "fatigue", "sleep impairment", "participation in social roles" and "activities"). The measures use a T-score metric in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population.
For the sub scales "participation in social roles and activities" and "physical functioning", a high score is interpreted as a good result and for the sub scales "anxiety", "depression", "fatigue", "impairment due to pain", and "sleep impairment" a low score is a good result.
Time frame: 10 minutes
to evaluate to subjective physical performance. A higher scores represent a better functional status.
Scores can be calculated for each of ten domains of the HAL and a sum score ("Lying / sitting / kneeling / standing" (8-48 Points), "Functions of the legs" (9-54 Points), "Functions of the arms" (4-24 Points), "Use of transportation" (3-18 Points), "Self care" (5-30 Points), "Household tasks" (6-36 Points), "Leisure activities and sports" (7-42 Points), "Upper Extremity Activities" (9-54 Points), "Basic Lower Extremity Activities" (6-36 Points), "Complex Lower Extremity Activities" (9-54 Points), and "Sum score" (42-252 Points).
Time frame: 15 minutes
Contact information is provided by the study sponsor or research team.
University Hospital, Bonn
Other
Prevalence of Synovitis in Adult Patients With Haemophilia A in Germany and Austria
Acronym: SynoPrev
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723560
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Bron, France
View Trial DetailsNCT07220564
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Aurora, Colorado, United States
View Trial DetailsNCT02207894
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT07437404
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Beijing, Beijing Municipality, China
View Trial Details